News Release

Thaumatin: natural sweetener with anti-inflammatory potential

In a cellular test system, digestive products of thaumatin can stimulate acid secretion by human stomach cells and influence inflammatory reactions

Peer-Reviewed Publication

Leibniz-Institut für Lebensmittel-Systembiologie an der TU München

PhD student Phil Richter working in the lab

image: 

PhD student Phil Richter working in the cell culture lab of the Leibniz Institute for Food Systems Biology

view more 

Credit: photo by G. Olias / Leibniz-LSB@TUM

A new study by the Leibniz Institute for Food Systems Biology at the Technical University of Munich shows for the first time that bitter tasting protein fragments (peptides) are produced in the stomach during the digestion of the natural sweetener thaumatin. In a cellular test system, the peptides are able to stimulate the acid secretion of human stomach cells and influence inflammatory reactions. “Our research helps to elucidate the health effects of the plant protein, which is widely used as a sweetener,” says Veronika Somoza, head of the study and director of the Leibniz Institute.

Veronika Somoza's team is researching, among other things, how bitter-tasting food compounds influence the metabolism of stomach cells and thus health. To this end, the team established a human gastric cell line (HGT-1 cells) as a test system. In earlier studies, the scientists had already shown that certain bitter substances interact with the stomach cells' own bitter taste receptors to stimulate the release of protons and thus the acid production of the cells. Such bitter substances also include peptides produced during the digestion of milk protein.

Building on earlier findings

“However, not only bitter tasting substances, but also the health effects of sweeteners are always in the focus of public interest. Based on our earlier findings, we therefore investigated whether bitter tasting peptides are also formed from the sweet tasting protein thaumatin in the stomach, which could have a physiological effect,” reports Phil Richter, first author and doctoral student at the Leibniz Institute.

Using studies on pigs, in vitro experiments and sensory tests, the team first identified three peptides that are produced during the digestion of thaumatin in the stomach and have a bitter taste. In the test system, the bitter peptides stimulated the release of protons from HGT-1 cells even at extremely low concentrations, i.e., in the nanomolar range.

In order to find out more about the potential anti-inflammatory effect of the three peptides, the team first investigated how the stomach cells of the test system generally react to the addition of Helicobacter pylori proteins. The bacterium H. pylori can cause inflammatory stomach diseases and even stomach cancer. Around half of the world's population is infected with this pathogen. In contrast to many other bacteria, it is able to survive in an extremely acidic stomach environment by neutralizing the low pH value of stomach acid, among other things.

Anti-inflammatory effect

As the team's test results show, H. pylori proteins induce an increased release of pro-inflammatory interleukin 17A in the test cells. “It is interesting that we were able to reduce the induced interleukin release of the gastric cells by up to 89.7 percent by adding one of the identified bitter tasting peptides. The gastric cell's own bitter taste receptor TAS2R16 was involved in this anti-inflammatory effect and also in the stimulation of proton release,” reports Phil Richter.

“The peptide concentrations tested in our study are based on realistic concentrations that can be achieved in the stomach by eating a commercially available sweetener tablet. Therefore, our results suggest that the anti-inflammatory potential of thaumatin or its bitter cleavage products as well as the functions of endogenous bitter taste receptors should be further investigated. Our aim is to better understand the molecular mechanisms of diet-related inflammatory gastric diseases. Not least with regard to infections with Helicobacter pylori,” explains Veronika Somoza.

Publication: Richter, P., Sebald, K., Fischer, K., Schnieke, A., Jlilati, M., Mittermeier-Klessinger, V., and Somoza, V. (2024). Gastric digestion of the sweet-tasting plant protein thaumatin releases bitter peptides that reduce H. pylori-induced pro-inflammatory IL-17A release via the TAS2R16 bitter taste receptor. Food Chem 448, 139157. 10.1016/j.foodchem.2024.139157. https://doi.org/10.1016/j.foodchem.2024.139157

More Information

About the study: The study was conducted by the Leibniz Institute for Food Systems Biology at the Technical University of Munich in cooperation with the Technical University of Munich (TUM) and was funded by the Leibniz Institute and TUM. The complete results have been published in the journal Food Chemistry.

Thaumatin is a protein that occurs naturally in the West African Katemfe fruit. It has long been known for its sweetening properties and also has a flavor-enhancing effect. As an EU-approved sweetener (E 957), it is frequently used in foods and drinks. Due to its intense sweetening power, which is around 1,600 times that of sucrose (household sugar), the daily intake by humans is rather low and its energy content of around four kilocalories per gram can be disregarded. A disadvantage, however, is that thaumatin loses its sweetening power when baked and cooked. However, heat does not impair its flavor-enhancing effect.

No ADI value has been set for thaumatin, as the body breaks down the protein completely. Even high intakes are considered toxicologically safe. The ADI (Acceptable Daily Intake) is the amount of a substance that a person can consume daily over a lifetime without fear of adverse health effects.

One nanomole corresponds to one billionth (1/1,000,000,000) of a mole, i.e., an extremely small amount of a substance. One mole of a substance corresponds to approx. 6 x 1023 particles.

Taste receptors for bitter are not only found on the tongue, but also on the surface of other tissues and cells. These include the parietal cells of the stomach, which secrete protons into the stomach - i.e., produce stomach acid.

Contacts:
Scientific Contact:

Prof. Dr. Veronika Somoza
Director of the Leibniz Institute for Food Systems Biology
at the Technical University of Munich (Leibniz-LSB@TUM)
Head of the Research Group Metabolic Function & Biosignals
Lise-Meitner-Str. 34
85354 Freising
E-mail: v.somoza.leibniz-lsb(at)tum.de

Phil Richter
Research Group Metabolic Function & Biosignals
Phone: +49 8161 71-2932
E-mail: p.richter.leibniz-lsb(at)tum.de

Press Contact at the Leibniz-LSB@TUM:

Dr. Gisela Olias
Knowledge Transfer, Press and Public Relations
Phone: +49 8161 71-2980
E-mail: g.olias.leibniz-lsb(at)tum.de
https://www.leibniz-lsb.de

Information About the Institute:

The Leibniz Institute for Food Systems Biology at the Technical University of Munich (Leibniz-LSB@TUM) comprises a new, unique research profile at the interface of Food Chemistry & Biology, Chemosensors & Technology, and Bioinformatics & Machine Learning. As this profile has grown far beyond the previous core discipline of classical food chemistry, the institute spearheads the development of a food systems biology. Its aim is to develop new approaches for the sustainable production of sufficient quantities of food whose biologically active effector molecule profiles are geared to health and nutritional needs, but also to the sensory preferences of consumers. To do so, the institute explores the complex networks of sensorically relevant effector molecules along the entire food production chain with a focus on making their effects systemically understandable and predictable in the long term.

The Leibniz-LSB@TUM is a member of the Leibniz Association, which connects 96 independent research institutions. Their orientation ranges from the natural sciences, engineering and environmental sciences through economics, spatial and social sciences to the humanities. Leibniz Institutes address issues of social, economic and ecological relevance.They conduct basic and applied research, including in the interdisciplinary Leibniz Research Alliances, maintain scientific infrastructure, and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer, particularly with the Leibniz research museums. It advises and informs policymakers, science, industry and the general public.

Leibniz institutions collaborate intensively with universities – including in the form of Leibniz ScienceCampi – as well as with industry and other partners at home and abroad. They are subject to a transparent, independent evaluation procedure. Because of their importance for the country as a whole, the Leibniz Association Institutes are funded jointly by Germany’s central and regional governments. The Leibniz Institutes employ around 21,300 people, including 12,200 researchers. The financial volume amounts to 2,2 billion euros.

+++ Stay up to date via our X (Twitter) channel twitter.com/LeibnizLSB +++

 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.